However, in some studies, TCRαβ+DNT has been found to potentially exert an immunosuppressive function in specific diseases, such as graft versus host disease (GVHD) and type 1 diabetes (T1D), by suppressing B-cell proliferation and producing IL-10 (28, 29). Here, IL10 is linked to graft versus host disease.